Weight gain and recurrence in idiopathic intracranial hypertension: A case-control study

Neurology

Volumn 76, Issue 18, 2011, Pages 1564-1567

  Ko, M W ^a,b,g   Chang, S C ^c   Ridha, M A ^a   Ney, J J ^f   Ali, T F ^d   Friedman, D I ^e   Mejico, L J ^a,b   Volpe, N J ^a   Galetta, S L ^a   Balcer, L J ^a,f   Liu, G T ^a  

^a Department of Neurology ^*  (United States)

^b SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

^c CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

^d PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^e UNIVERSITY OF ROCHESTER   (United States)

^f UNIVERSITY OF PENNSYLVANIA   (United States)

^g UHCC Neurology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIURETIC AGENT;

ADULT; ARTICLE; BODY MASS; CASE CONTROL STUDY; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DIPLOPIA; FEMALE; FOLLOW UP; HEADACHE; HUMAN; HYPERTENSION; IDIOPATHIC INTRACRANIAL HYPERTENSION; MEDICAL RECORD REVIEW; PERCEPTION OF VISUAL FIELD DEFECT; PRIORITY JOURNAL; PULSATILE TINNITUS; RECURRENT DISEASE; TRANSIENT VISUAL OBSCURATION; VISUAL DISORDER; WEIGHT CHANGE; WEIGHT GAIN; WILCOXON SIGNED RANKS TEST;

EID: 79955627519     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e3182190f51     Document Type: Article

References (10)

1. Sinclair AJ, Burdon MA, Nightingale PG, et al. Low energy diet and intracranial pressure in women with idiopathic intracranial hypertension: prospective cohort study. BMJ 2010;341:c2701.
2. Johnson LN, Krohel GB, Madsen RW, March GA Jr. The role of weight loss and acetazolamide in the treatment of idiopathic intracranial hypertension (pseudotumor cerebri). Ophthalmology 1998;105:2313-2317. (Pubitemid 30191677)
3. Kupersmith MJ, Gamell L, Turbin R, Peck V, Spiegel P, Wall M. Effects of weight loss on the course of idiopathic intracranial hypertension in women. Neurology 1998;50: 1094-1098. (Pubitemid 28212843)
4. Daniels AB, Liu GT, Volpe NJ, et al. Profiles of obesity, weight gain, and quality of life in idiopathic intracranial hypertension (pseudotumor cerebri). Am J Ophthalmol 2007;143:635-641.
5. Durcan FJ, Corbett JJ, Wall M. The incidence of pseudotumor cerebri: population studies in Iowa and Louisiana. Arch Neurol 1988;45:875-877.
6. Radhakrishnan K, Ahlskog JE, Cross SA, Kurland LT, O'Fallon WM. Idiopathic intracranial hypertension (pseudotumor cerebri): descriptive epidemiology in Rochester, Minn, 1976 to 1990. Arch Neurol 1993;50:78-80. (Pubitemid 23019204)
7. Friedman DI, Jacobson DM. Diagnostic criteria for idiopathic intracranial hypertension. Neurology 2002;59: 1492-1495. (Pubitemid 35387052)
8. Kesler A, Hadayer A, Goldhammer Y, Almog Y, Korczyn AD. Idiopathic intracranial hypertension: risk of recurrences. Neurology 2004;63:1737-1739. (Pubitemid 39507606)
9. Shah VA, Fung S, Shahbaz R, Taktakishvili O, Wall M, Lee AG. Long-term follow-up of idiopathic intracranial hypertension: the Iowa experience. Neurology 2008;70: 634-640. (Pubitemid 351294641)
10. Physical status: the use and interpretation of anthropometry: report of a WHO expert committee. World Health Organ Tech Rep Ser 1995;854:1-452.